ORG-201745: Difference between revisions
Content deleted Content added
No edit summary |
|||
| Line 56: | Line 56: | ||
}} |
}} |
||
'''ORG-201745''' is a [[progestin]] which was originated by [[Organon]] and was under development by [[Schering-Plough]] (which acquired Organon in 2007) for the treatment of "[[female genital disease]]s" and as a [[hormonal contraceptive]] for the prevention of [[pregnancy]] but was never marketed.<ref name="AdisInsight">https://adisinsight.springer.com/drugs/800027574</ref> |
'''ORG-201745''' is a [[progestin]] which was originated by [[Organon]] and was under development by [[Schering-Plough]] (which acquired Organon in 2007) for the treatment of "[[female genital disease]]s" and as a [[hormonal contraceptive]] for the prevention of [[pregnancy]] but was never marketed.<ref name="AdisInsight">{{cite web |url=https://adisinsight.springer.com/drugs/800027574 | title=ORG 201745 - AdisInsight |website=adisinsight.springer.com}}</ref> |
||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
==External links== |
|||
* [https://adisinsight.springer.com/drugs/800027574 ORG-201745 - AdisInsight] |
|||
{{Progesterone receptor modulators}} |
{{Progesterone receptor modulators}} |
||
Revision as of 19:02, 21 November 2018
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
References
- ^ "ORG 201745 - AdisInsight". adisinsight.springer.com.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |